Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Vera Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
Revenues34.652.50.0
            Revenue growth-34.1%  
Cost of goods sold0.00.00.0
Gross profit34.652.50.0
            Gross margin100.0%100.0% 
Research and development22.545.27.3
General and administrative11.94.04.4
EBIT-34.4-49.2-11.7
            EBIT margin-99.5%-93.8% 
Pre-tax income-32.6-53.4-11.9
Income taxes0.00.00.0
Net income-32.6-53.4-11.9
            Net margin-94.3%-101.8% 
 
Diluted EPS($2.43)($166.93)($40.14)
Shares outstanding (diluted)13.40.30.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy